Gambaran Umum
Ang Biocure Technology Inc. ay isang biopharmaceutical na kumpanya na nakabase sa Vancouver, Canada. Pangunahin itong nagpapatakbo sa loob ng industriya ng bioteknolohiya, na nakatuon sa pagbuo at pagkomersyal ng mga produktong biosimilar na parmasyutiko. Kabilang sa mga pangunahing proyekto ng Biocure ang pananaliksik at pagpapaunlad sa mga biosimilar na nagta-target ng mga sakit gaya ng leukemia, at rheumatoid arthritis. Kabilang sa mga makabuluhang pakikipagsapalaran ng kumpanya ang pagbuo ng CAR T-cell therapies, isang pioneering area sa paggamot sa kanser na kinasasangkutan ng genetically modified T-cells upang labanan ang mga cancer cells nang mas epektibo. Sa pamamagitan ng paggamit ng makabagong teknolohiya at malawak na pananaliksik, layunin ng Biocure na magbigay ng abot-kaya, mataas na kalidad na mga biopharmaceutical na solusyon upang matugunan ang mga kumplikadong pangangailangang medikal, habang nagsusumikap na makamit ang mga therapeutic advancement sa mga merkado sa Canada at sa buong mundo.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Biocure Technology Inc. per 2025 Jun 30 adalah -0.21 MM.
- Nilai net income untuk Biocure Technology Inc. per 2025 Jun 30 adalah -0.25 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -0.21 | -0.25 | |
2025-03-31 | -0.26 | -0.25 | |
2024-12-31 | -0.32 | -0.26 | |
2024-09-30 | -0.96 | -4.06 | |
2024-06-30 | -1.01 | -4.17 | |
2024-03-31 | -1.04 | -1.52 | |
2023-12-31 | -1.05 | -1.81 | |
2023-09-30 | -0.61 | 1.62 | |
2023-06-30 | -0.62 | 1.44 | |
2023-03-31 | -0.64 | -1.46 | |
2022-12-31 | -0.67 | -1.45 | |
2022-09-30 | 2.38 | 2.33 | |
2022-06-30 | 0.97 | 1.23 | |
2022-03-31 | -0.48 | -0.05 | |
2021-12-31 | -1.73 | -1.13 | |
2021-09-30 | -6.04 | -5.76 | |
2021-06-30 | -4.95 | -4.79 | |
2021-03-31 | -3.82 | -3.71 | |
2020-12-31 | -3.07 | -2.95 | |
2020-09-30 | -0.00 | -2.94 | -3.09 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -1.06 | -1.06 |
2024-06-30 | -0.44 | -0.44 |
2024-03-31 | -0.15 | -0.15 |
2023-12-31 | -0.18 | |
2023-09-30 | 0.02 | 0.02 |
2023-06-30 | 0.12 | 0.12 |
2023-03-31 | -0.12 | -0.12 |
2022-12-31 | -0.09 | |
2022-09-30 | 0.20 | 0.20 |
2022-06-30 | 0.10 | 0.10 |
2022-03-31 | -0.00 | -0.00 |
2021-12-31 | -0.09 | |
2021-09-30 | -0.49 | -0.49 |
2021-06-30 | -0.43 | -0.43 |
2021-03-31 | -0.34 | -0.34 |
2020-12-31 | -0.27 | |
2020-09-30 | -0.29 | -0.29 |
2020-06-30 | -0.32 | -0.32 |
2020-03-31 | -0.44 | -0.44 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Biocure Technology Inc. per 2025 Jun 30 adalah -0.08 MM.
- Nilai kas dari aktivitas pendanaan untuk Biocure Technology Inc. per 2025 Jun 30 adalah 0.10 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -0.08 | 0.10 | |
2025-03-31 | 0.00 | ||
2024-12-31 | 0.01 | ||
2024-09-30 | 0.07 | 0.00 | -0.05 |
2024-06-30 | 0.07 | 0.00 | -0.05 |
2024-03-31 | 0.03 | 0.02 | -0.06 |
2023-12-31 | -0.22 | 0.04 | 0.14 |
2023-09-30 | -0.45 | 0.08 | 0.32 |
2023-06-30 | -0.53 | 0.08 | 0.39 |
2023-03-31 | -0.50 | 0.10 | 0.33 |
2022-12-31 | -0.83 | 0.07 | 0.63 |
2022-09-30 | -0.76 | 0.07 | 0.56 |
2022-06-30 | -1.36 | 0.07 | 0.99 |
2022-03-31 | -1.49 | 0.03 | 1.53 |
2021-12-31 | -1.08 | 0.03 | 1.17 |
2021-09-30 | -1.36 | 0.09 | 1.45 |
2021-06-30 | -0.86 | 0.09 | 1.14 |
2021-03-31 | -1.06 | 0.09 | 0.65 |
2020-12-31 | -1.31 | 0.09 | 1.13 |
2020-09-30 | -1.53 | -0.49 | 1.90 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Biocure Technology Inc. pada 2025 Jun 30 adalah -0.12.
- roe untuk Biocure Technology Inc. pada 2025 Jun 30 adalah -0.16.
- roic untuk Biocure Technology Inc. pada 2025 Jun 30 adalah -0.18.
- croic untuk Biocure Technology Inc. pada 2025 Jun 30 adalah 0.00.
- ocroic untuk Biocure Technology Inc. pada 2025 Jun 30 adalah 0.00.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.12 | -0.16 | -0.18 | 0.00 | 0.00 |
2025-03-31 | -2.05 | -0.16 | -2.54 | 0.01 | 0.04 |
2024-12-31 | -2.05 | -0.16 | -2.47 | 0.01 | 0.04 |
2024-09-30 | -1.16 | -1.57 | -2.47 | 0.01 | 0.04 |
2024-06-30 | -0.74 | -0.94 | -0.00 | 0.02 | |
2024-03-31 | -0.87 | -1.05 | -0.02 | -0.13 | |
2023-12-31 | 0.78 | 0.61 | -0.02 | -0.17 | |
2023-09-30 | 0.68 | 0.52 | -0.02 | -0.19 | |
2023-06-30 | 0.68 | 0.52 | -0.02 | -0.19 | |
2023-03-31 | -0.62 | ||||
2022-12-31 | 0.53 | 2.87 | -0.16 | -0.93 | |
2022-09-30 | 0.53 | 2.87 | -0.16 | -0.93 | |
2022-06-30 | 0.26 | 0.53 | -0.13 | -0.58 | |
2022-03-31 | -0.01 | -0.02 | 0.10 | -0.50 | |
2021-12-31 | -0.25 | -0.38 | 0.04 | -0.37 | |
2021-09-30 | -1.16 | -22.15 | 0.68 | -5.22 | |
2021-06-30 | -0.95 | -13.84 | 1.06 | -2.47 | |
2021-03-31 | -0.78 | -2.56 | -0.21 | -0.73 | |
2020-12-31 | -0.64 | -1.76 | -0.05 | -0.78 | |
2020-09-30 | -0.75 | -2.90 | -1.04 | -0.03 | -0.52 |
2020-06-30 | -0.84 | -3.40 | -1.07 | 0.00 | -0.67 |
2020-03-31 | -1.30 | -3.23 | -1.41 | 0.04 | -0.62 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | 0.72 | 1,196.68 | 1,231.85 |
2020-12-31 | 0.72 | 949.27 | 988.30 |
2020-09-30 | 0.72 | 997.11 | 945.95 |
2020-06-30 | 0.81 | 2,328.62 | 2,218.40 |
2020-03-31 | 0.65 | 64.54 | 62.37 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |